WEC
VNRX icon

Winslow Evans & Crocker’s VolitionRx Ltd VNRX Stock Holding History

Winslow Evans & Crocker’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17
Closed -$1K – 1162
2020
Q2 		$1K Hold
17
– – ﹤0.01% 1109
2020
Q1 		$2K Hold
17
– – ﹤0.01% 1072
2019
Q4 		$2K Hold
17
– – ﹤0.01% 1117
2019
Q3 		$2K Buy
+17
New +$1.35K ﹤0.01% 1110

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Winslow Evans & Crocker's VNRX Position: Q3 2020 in Review

Winslow Evans & Crocker sold out of VolitionRx Ltd (VNRX) in Q3 2020, closing a stake of 17 shares — an estimated $1K sold.

Winslow Evans & Crocker first reported a position in VNRX in Q3 2019 and held it in 4 quarters. The position peaked at $2K in Q1 2020. 47 funds tracked by Wall St. Rank hold VNRX as of Q3 2020.

  • Winslow Evans & Crocker reported no remaining VolitionRx Ltd position as of Q3 2020 after selling out during the quarter.
  • Winslow Evans & Crocker sold 17 VolitionRx Ltd shares in Q3 2020, an estimated $1K.
  • Winslow Evans & Crocker first reported a position in VolitionRx Ltd in Q3 2019 and held it in 4 quarters.
  • Winslow Evans & Crocker's VolitionRx Ltd position peaked at $2K in Q1 2020.
  • 47 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q3 2020.

Based on Winslow Evans & Crocker's 13F filing for Q3 2020, filed 21 Oct 2020.